Respironics recall creates billing concerns for suppliers
One of the most discussed topics in the last month has been that of the recall by Philips Respironics. As you may know, on June 14th, 2021, Philips announced a voluntary, global recall of approximately 4 million continuous positive airway pressure (CPAP) devices, bilevel respiratory assist devices (BIPAP), and ventilators. The issue was, in essence, that Philips advised that there are potential health risks related to sound abatement foam used in specific Philips devices. The company has developed a comprehensive plan to replace the current sound abatement foam with a new material that is not affected by this issue and has already begun this process. This created quite the impact across the nation as suppliers were caught off-guard while Philips worked through the specifics of the recall. In response, Philips made the following announcement on their website: